The original version of the abstract 270 on S68 unfortunately contained mistakes. The correct version is given below. ii . Yet, further evidence on the safety is still necessary, in particular for the use in pregnancy.
Objectives: The ECVAM validated Embryonic Stem Cell Test (EST)
iii is employed to determine the embryotoxicity potential of the PHF formula and the individual components.
Methods & Results:
Chromatography technologies (TLC and/or HPLC) were used for chemical authentications to ensure the quality of each test herbal extract. The commercially available permanent mouse embryonic stem cell line D3 and mouse fibroblast cell line 3T3 were applied to the cytotoxicity and differentiation experiments. The embryotoxic potential was derived from the biological and molecular endpoints (ID 50D3 , IC 503T3 and IC 50D3 ). According to the linear discriminant functions, both the formula PHF and its individual herbal extracts are classified as non-embryotoxic.
Conclusions:
Our study provides evidence on the safety of the formula PHF, which could be used as an adjunctive treatment for AD during pregnancy.
